Reuters logo
BRIEF-A1M Pharma files patent application​
November 7, 2017 / 7:53 AM / a month ago

BRIEF-A1M Pharma files patent application​

Nov 7 (Reuters) - A1M PHARMA AB:

* ‍PRECLINICAL STUDIES SHOWS A PROTECTIVE EFFECT OF CANDIDATE DRUG ROSGARD ON BONE MARROW​

* ‍FILED A PATENT APPLICATION​

* ‍WILL INCLUDE BIOMARKERS FOR BONE MARROW PROTECTION IN COMPANY‘S SCHEDULED CLINICAL PROGRAM FOR ROSGARD​

* AIMS TO INITIATE CLINICAL STUDIES FOR KIDNEY PROTECTION IN CONNECTION WITH RADIATION THERAPY DURING Q1 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below